Blog

Although it is classified as a blood thinner/Factor Xa inhibitor, the anti-coagulant drug XARELTO® has been approved by the U.S. Food and Drug Administration (FDA) for another use. A recent report shows that it can be taken to reduce the risks of peripheral artery disease (PAD), chronic coronary disease (CAD), strokes, other cardiovascular events, and » Read More